Streamline Your Discoveries with One Line of Consumables

Whether you’re in early-stage discovery or ready to accelerate development, ExPERT processing assemblies, reagents, and accessories help you scale consistently without compromising efficiency. Reach your destination with ease with MaxCyte consumables.

Propel Your Research to the Clinic with Simple and Adaptable Products


Processing Assemblies

ExPERT PAs ‘Processing Assemblies’ for R&D and cGMP development

Advance your project goals and milestones while maintaining the high levels of efficiency, viability, and consistency your therapy deserves.


Reagents & Supporting Products

MaxCyte reagents and accessories for quick and easy electroporation discovery.

Develop protocols and handle precious samples confidently with one line of compatible reagents and accessories.

Processing Assemblies Scales & Available Formats

Sample Volumes* Cell Numbers* Formats Available
15 µL - 25 µL 75,000 to 5 million cells 3 well PA
45 µL - 55 µL 225,000 to 10 million cells 3 well and 8 well PAs
50 µL - 100 µL 250,000 to 20 million cells 1 well and 2 well PAs
200 µL - 400 µL 1 million to 80 million cells 1 well PA
400 µL - 1 mL 2 million to 200 million cells 1 well PA
1 mL - 3.5 mL 5 million to 700 million cells 1 well, closed PA
5 mL - 20 mL 200 million to 4 billion cells Flow EP closed bag system
10 mL - 100 mL 50 million to 20 billion cells Flow EP closed bag system
100 mL - 1000 mL 10 billion to 200 billion cells Flow EP VLx PA system
Calculations for lower limits based on a cell concentration of 1x107/mL and for the upper limit 2x108/mL
*Cell numbers and volumes are for a single well

Choosing MaxCyte gives you more than just an instrument — you get cell engineering and regulatory expertise that moves you from concept to clinic faster.


Large-Scale Engineering of Extracellular Nanoparticles for Genome Editing with CRISPR-Cas9 Ribonucleoproteins

Despite advances in human genetics, patients with rare diseases such as Duchenne muscular dystrophy (DMD) still have limited therapeutic options and a short life expectancy.

Efficient and Scalable T Cell Engineering for Advancing Cancer Immunotherapy of Hepatocellular Carcinoma by a cGMP-Compliant Non-Viral Cell Engineering Platform

Chronic hepatitis B virus (HBV) infection can result in hepatocellular carcinoma (HCC), which is the third leading cause of cancer-related deaths worldwide.

Hematopoietic Stem Cell Electroporation for HDR-Mediated Correction of an X-Linked Blood Disorder

Wiskott-Aldrich Syndrome (WAS) is an X-linked recessive primary immunodeficiency affecting between 1 in 50,000 to 1 in 250,000 live births worldwide. Mutations in the WAS gene cause abnormal immune system function, thrombocytopenia, and an increased incidence of autoimmune malignancies.

Transfect any cell or any molecule at any scale with MaxCyte’s platform technology

With electroporation devices to meet every need and technical support for every stage, you can transfect any cell or molecule with high efficiency, potency, and reproducibility.


MaxCyte’s electroporator technology can help you scale to up to 200 billion highly viable cells.


Experience Best-In-Class Cell Engineering Platforms

Accelerate your therapy by combining comprehensive and personalized scientific and regulatory support with industry leading electroporation systems.